Wednesday, November 17, 2021 4:53:43 PM
The following comes from the analyst following us as reported by Yahoo and the WSJ-Markets.
FWIW, this one analyst’s recommendation is ‘Strong Buy’ and he foresee the 2021 revenues at $7,07M (Q2 was $1.1M) and the 2022’s at $49,57M.
This analyst also predicts a stock price target of $5,57.
On the basis of 120,000,000 O/S, that would mean a MC of $690,000,000 or 13.5 times (???) 2022 revenues.
Let’s see if tomorrow’s conference will attract additional analysts and institutional investors.
We however still have to live with an OTC listing and a company not regularly filing with SEC, 2 handicap the company will have to address sooner than later.
On that ... I wish you a good night and a great day tomorrow ... hopefully
Patiently,
Roger
Recent BABYF News
- Nutrition Firm Expanding into the Fast Growing Kids Market • AllPennyStocks.com • 08/03/2023 04:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM